Check often for updates.

  • Last update 11/27/2020
  • We check instructions to identify any explicit prohibitions on applications from US academic institutions but we do not enter the application system or communicate with funders to confirm details.
Newest Opportunities – Week of November 23, 2020

Directory:

National Institutes of Health Funding Opportunities
Other Federal Funding Opportunities
Foundations and Other Funding Opportunities
Challenges & Innovation Accelerator Competitions
Other COVID Funding Compilations

We update most items daily and also crowd-source information to aim for comprehensive representation of opportunities for those in US academic settings with breadth of disciplines. These are cross-checked weekly.

For details about the funding sources and compilations for which we conduct scheduled surveillance for funding opportunities, this is the working document enumerating sources and links: bit.ly/34HBOt8

Please suggest additions of funding opportunities in comments.

National Institutes of Health

General Communications for Awardees & Those Submitting Grants

NIH Administrative Supplements:

If you currently have an active NIH grant, you may be eligible to apply for an administrative supplement to support COVID-19 research. Administrative supplements are non-competing awards that provide additional funding to a currently funded grant to meet increased costs that are within the scope of the approved project. Contact program official to discuss. Parent funding opportunity is PA-18-591.

NIH Competitive Revisions:

Multiple NIH Institutes & Offices

(OBSSR, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI, NICHD, NINR, NHGRI)
Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus & the Behavioral and Social Sciences
  • Due: Rolling through March 31, 2021
  • Funding: $100,000 direct costs per year
  • Project period: Up to 2 years
  • Purpose: To encourage supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.
(OPPNET, NIA, NIAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH)
Notice of Additional Due Date and Areas of Focus of “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)”
  • Due: March 17, 2021
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing. Notice adds specific interest in COVID-19 responses.
(NIMHD, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NINR, NCCIH, NCATS)
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
  • Due: December 1, 2020
  • Funding: Up to $500,000 direct costs annually
  • Project period: Up to 5 years
  • Purpose: To evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission and acquisition; and 2) already implemented, new, or adapted interventions to address the adverse consequences of the pandemic on the health of these groups.
(NIMH, NCATS, NCCIH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMHD, NINR)
Notice of Special Interest: Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
  • Due: Rolling through December 15, 2020
  • Funding: Up to $200,000 direct costs
  • Project period: 1 year (2 years with justification)
  • Purpose: To support research to address secondary health effects of the social, behavioral, and economic changes, particularly among populations who experience health disparities and vulnerable populations through the use of digital health assessments and interventions to yield measurable near-term impact.
(NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NCCIH, NCATS)
Notice of Special Interest: Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations
  • Due: Rolling through December 15, 2020
  • Funding: Up to $250,000 per year, direct costs
  • Project period: 1 year (2 years with justification)
  • Purpose: To test community interventions focused on the prevention (or slowing) of COVID-19 transmission, evaluate local and state policies and programs intended to mitigate COVID-19 exposure and improve adherence, and reduce the negative impact of the multifaceted consequences on the health of populations who experience health disparities and other vulnerable groups.
(OD, NHLBI, NHGRI, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NIMHD, NCCIH, NCATS, ORIP, NCI)
Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
  • Due: March 12, 2021; July 12, 2021
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population.
(NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NIMHD, NCCIH, NCATS)
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional)
  • Due: December 2, 2020; March 2, 2021
  • Funding: Up to $750,000 per year, direct costs
  • Project period: Up to 3 years
  • Purpose: To determine the role and impact of digital health interventions to address secondary health effects of the social, behavioral, and economic changes following the COVID-19 pandemic, particularly among populations who experience health disparities and vulnerable populations.
(NIA, NIMH, NIAAA, NINDS)
Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health & Health Disparities
  • Due: Rolling through May 1, 2021
  • Project period: 1 year, with possible second year
  • Purpose: To highlight urgent need for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations.
(NIMH, NIAAA)
Notice of Special Interest: Administrative Supplements & Revision Supplements on COVID-19
  • Due: Rolling until May 1, 2021
  • Funding: Not specified
  • Project period: 1 year, with possible second year
  • Purpose: To support mission critical areas of research for NIA as they relate to the COVID-19 pandemic. Research interests are provided by the Division of Aging Biology, Division of Neuroscience, and the Division of Behavioral and Social Research.
  • FAQs here: NOT-AG-20-031

National Cancer Institute (NCI)

Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis

National Center for Advancing Translational Sciences (NCATS)

Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)
  • Due: Rolling through January 24, 2021
  • Funding: Up to $3 M, direct costs per year
  • Project period: Up to 3 years
  • Purpose:  To repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. 
Notice of Special Interest: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
  • Due: Receipt dates through March 17, 2021
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.
  • Notes: Grant types include UG3/UH3, U34, U01
Limited Competitions (UL1/U01/U24/R21) to current CTSA awardees to address COVID-19 public health needs
  • Due: Variable dates through July 2021
  • Purpose: To use informatics solutions to diagnose cases and use CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. 
Notice of Special Interest: Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
  • Due: Rolling through January 25, 2022
  • Project period: 1 year
  • Purpose: To use microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and to advance the translation of research findings into diagnostics, therapeutics, and vaccines.
Notice of Special Interest: Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
  • Due: Rolling through January 25, 2022
  • Purpose: To use microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and to advance the translation of research findings into diagnostics, therapeutics, and vaccines.

National Institute of Allergy & Infectious Diseases (NIAID)

NIAID COVID-19 research priorities
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
  • Due: Rolling until July 8, 2021
  • Funding: Reflect actual need
  • Project period: Up to 1 year
  • Purpose: To provide personal protective equipment to directly support the needs of the NIAID’s vaccine and treatment clinical trials for COVID-19. Eligibility is limited to clinical trials and clinical studies supported by NIAID’s emergency appropriation.
Notice of Special Interest: Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • Due: Rolling until July 2, 2021
  • Funding: Not more than annual amount of current parent award
  • Project period: Up to 2 years
  • Purpose: To increase and enhance select research efforts to facilitate the SARS-CoV-2/COVID-19 research response. Areas of interest are limited to: 1) current BSL3 facilities, 2) generation of critical reagents, 3) expansion of data systems, and 4) expansion of clinical trial infrastructure.
Notice of Special Interest: Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
  • Due: Monthly through September 1, 2021
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To encourage cooperative agreement applications for implementation of investigator-initiated high-risk clinical trials that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Notice of Special Interest: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
  • Due: Standard dates beginning February 5, 2021
  • Funding: Not specified; see related R01, R03, and R21 notices
  • Project period: Not specified; see related R01, R03, and R21 notices
  • Purpose: To understand 1) the rehabilitation needs of COVID-19 survivors, 2) the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions, and 3) the impact of delayed treatment for common disabling conditions such as stroke.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)
  • Due: December 16, 2020
  • Funding: $250,000 per year, direct costs
  • Project period: Up to 3 years
  • Purpose: To delineate and address mechanisms by which people with diseases in the mission of NIDDK have poor outcomes from SARS-CoV-2 infection, including variable susceptibility, altered course of disease, morbidity, and mortality.

National Institute of Environmental Health Sciences (NIEHS)

Notice of Special Interest: Support for Understanding the Impact of Environmental Exposures on COVID-19 
  • Due: Monthly, through May 3, 2021
  • Project period: 1 year
  • Purpose: To promote rapid understanding of the potential contributions of current and past exposure to environmental agents that may exacerbate COVID-19 susceptibility, disease severity, and progression.
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21)
  • Due: Monthly through October 4, 2022
  • Project period: 2 years
  • Purpose:  To understand the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad. Entire cycle, from submission to award, is expected to be within 3-4 months. Use this mechanism if you are applying for a new R21 grant that does not build off of an existing NIEHS grant.

National Institute of General Medical Sciences (NIGMS)

Guidance for Cost-Related Flexibilities for SCORE Award Recipients Affected by COVID-19
Notice of Special Interest: Emergency Competitive Revisions for Research on SARS-CoV-2 and COVID-19
  • Due: Rolling through February 5, 2021
  • Funding: Not more than amount of current parent award
  • Project period: 1 year
  • Purpose: To address only: 1) Incorporation of data related to SARS-CoV-2 into ongoing predictive modelling efforts for spread of SARS-CoV-2 and other related infectious agents; 2) Repurposing or modifying diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR grants only); 3) Rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR only).

National Institute of Mental Health (NIMH)

Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19)
  • Purpose: To reduce proliferation of one-off survey items and to facilitate data integration, collaboration, and comparisons across data sets pertaining to mental health outcomes and experiences during the COVID-19 public health emergency and exposures to the SARS-CoV-2 virus.
Notice of Special Interest: Administrative Supplements and Revision Supplements on COVID-19
  • Due: Rolling through May 1, 2021
  • Project period: 1 year, with possible second year
  • Purpose: To examine how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or worsening mental health needs and/or suicide risk in midlife and older age adults will be seen as a high priority.
Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Mental Health Research on 2019 Novel Coronavirus
  • Due: Rolling through April 15, 2021
  • Purpose: To provide an evidence base for how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, as well as to learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest.

National Institute of Neurological Disorders and Stroke (NINDS)

Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
  • Due: Rolling through April 14, 2021
  • Funding: Up to $200,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects on the nervous system of its causative agent, SARS-CoV-2. 

National Institute on Aging (NIA)

Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
  • Due: Monthly, through February 1, 2020
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To support clinical trials of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19).

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest: Administrative Supplements & Competitive Revision Supplements on COVID-19 Within Mission of NIAAA
  • Due: Rolling through April 15, 2021
  • Funding: Up to $100,000 per year; exceptions require permission
  • Project period: Up to 2 years
  • Purpose: To understand relationships between alcohol consumption and COVID-19 related-outcomes to enhance the nation’s response to the current pandemic.

National Institute on Drug Abuse (NIDA)

Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions for Research on COVID-19
  • Due: Rolling until April 1, 2021
  • Funding: $100,000 per year
  • Project period: 2 years
  • Purpose: To support research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.
Notice of Special Interest: Effects of smoking and vaping on the risk and outcome of COVID-19 infection
  • Due: Standard dates through September 8, 2024
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To research the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection.
  • Notes: Grant types: R01, R03, R21

National Institute on Deafness and Other Communication Disorders (NIDCD)

Notice of Special Interest: NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
  • Due: Standard dates through September 8, 2022
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To invite research on COVID-19 in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech and language (HBTSVSL).

Other Federal Funding Opportunities:

Biomedical Advanced Research & Development Authority

Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement
  • Due: Rolling through February 3, 2023
  • Funding: Negotiated
  • Purpose: To fund COVID-19 related research in the development of diagnostics and/or vaccines.

Department of Energy

Invitation to send research questions
  • Due: Rolling review
  • Purpose: To identify scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.

Department of State

COVID-19 Private Sector Engagement & Partnership Fund
  • Due: May 28, 2021 
  • Funding: $50,000 – $1,000,000
  • Project period: 12 to 36 months
  • Purpose: The Department is specifically looking for concept papers that will enable people around the world to mitigate the COVID-19 virus’s effects on their societies
  • Eligibility Notes: U.S. non-profit/non-governmental organizations (NGOs) having a 501(c)(3) status with the IRS, overseas-based non-profit/non-governmental organizations, U.S. and overseas private/state institutions of higher education, and for-profit and commercial firms.

National Aeronautics and Space Administration

Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of the COVID-19 pandemic
  • Due: March 29, 2021
  • Funding: $100,000
  • Project period: 1 year
  • Purpose: To address environmental, economic, and/or societal impacts of the COVID-19 pandemic.

National Science Foundation

RAPID Funding Mechanism for COVID-19 Related Investigations
  • Due: Follow application type
  • Funding: Up to $200,000 via RAPID
  • Project period: Up to 1 year via RAPID
  • Purpose: To encourage submissions to existing opportunities via the RAPID funding mechanism for COVID-19-related investigations.

NSF: Office of Advanced Cyberinfrastructure

Provisioning Advanced Cyberinfrastructure to Further Research on COVID-19
  • Due: Rolling
  • Funding: Not specified
  • Purpose: To invite RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.

Patient-Centered Outcomes Research Institute

Applicant and awardee FAQs for COVID-19 projects.

US Agency for International Development – Bangladesh

USAID/Bangladesh and the Private Sector: Partnering to Fight COVID-19
  • Due: April 29, 2021
  • Funding: $900,000 to $10.0 M
  • Project period: Not specified
  • Purpose: To provide a medium through which organizations can work with USAID and the private sector to build Global Development Alliances (that will: a) respond to the current outbreak of COVID-19 in Bangladesh; b) address important business interests and objectives; and c) advance USAID’s strategic priorities and objectives. Interventions awarded through this program may address the immediate concerns and impacts of COVID-19 as well as long term or secondary impacts such as those on food security or the garments sector, as well as promote peace, stability, human rights, and gender equity.

Non-Federal Opportunities & Consortia:

23andMe

COVID-19 Study
  • Next Innovation Collaboration deadline: January 4, 2021
  • Purpose: To uncover genetic risks associated with severe outcomes of infections by SARS-CoV-2.
  • Note: Soliciting participation in a collaborative study. Contact information provided for investigators who would like to partner with 23andMe.

Berytech Fab Lab

HealthTech Solutions Initiative: Prototyping Solutions for the Coronavirus Crisis
  • Due: Open
  • Funding: $10,000 for prototyping
  • Project period: Not specified
  • Purpose: To support teams working on a health technology solution including test kits, respiratory devices, protective equipment or mobile applications for detection, tracing, and information sharing, that can respond immediately to the coronavirus crisis and the current emergency medical needs for Lebanon.

Biogen

COVID-19 Relief
  • Due: Open
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To provide relief focused on the following categories: 1) expanding and ensuring access to testing, 2) easing the burden on healthcare systems and healthcare workers, 3) providing food and necessities for our most vulnerable populations.
  • Eligibility Notes: Must be a 501(c)3 organization.

Boehringer Ingelheim

IIS Program i – Established Products
  • Due: Open
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: Supporting clinical and non-clinical investigations involving COVID-19 related matters including safety, clinical outcomes, antiviral effects, or antithrombotic benefits.
  • Eligibility Notes: Applicants must be U.S. academic or community- based scientists individually or through consortia.

California Health Care Foundation

Unsolicited requests – Letter of Inquiry
  • Due: Open
  • Funding: Not specified
  • Purpose: To advance improvements in the health care delivery system for the people of California, particularly those with low incomes and those whose needs are not well served by the status quo.

Cisco Systems, Inc.

Pandemic/COVID19 Science, Technology and Social Impact
  • Due: Open
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To provide solutions ranging from predictive analytics innovative devices for saving lives to technology for devising voting machines.

Expo 2020 Dubai

COVID-19 Call for Proposals
  • Due: December 31, 2020
  • Funding: Not specified
  • Project period: Awardee exhibited for 6 months
  • Purpose: Call for best practices proposals that address issues related to COVID-19.
  • Eligibility Notes: Participation will be based on principles of inclusion and diversity. Eligible candidates include governments of all nations, corporations and businesses, international organizations, public organizations or associations, universities and educational institutions, public-private partnerships, communities, individuals, entrepreneurs, and inventors.

Extreme Science and Engineering Discovery Environment (XSEDE)

COVID-19 HPC Consortium
  • Due: Rolling
  • Resources: Access to computing capabilities from some of the most powerful and advanced computers in the world
  • Purpose: To empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections via exceptional computational resources and collaborations. 
  • Eligibility Notes: 3 page application must describe need for high-performance computing and have high-performance computing knowledge and experience on the proposing team.

Fast Grants

Fast Funding for COVID-19 Science
  • Due: Submission is currently on pause.
  • Funding: $10,000 to $500,000
  • Project period: 6 months
  • Purpose: To expedite COVID-19-related science.
  • Eligibility Notes: Available to scientists at academic institutions currently working on COVID-19 related projects and in need of funding.

Foundation for a Smoke-Free World 

Health, Science, and Technology RFP
  • Due: December 15, 2020
  • Funding: $150,000 – $500,000
  • Project period: 3 months – 1 year
  • Purpose: To better understand the associations between smoking and / or nicotine use, and COVID-19 infection and outcomes.
  • Eligibility Notes: The Foundation encourages participation by groups whose work aligns with the Foundation’s mission to eliminate smoking within a generation. These groups may include institutions of higher education, nonprofits, commercial enterprises, governmental agencies, or other research-based organizations.

Gates Foundation

No open requests for investigator-initiated applications related to COVID-19 are available at this time. Current funding is directed to the COVID-19 Therapeutics Accelerator in collaboration with Wellcome and Mastercard, as well as targeted international efforts.

Google Cloud

COVID-19 Research Credits Program
  • Due: Open
  • Funding: Not specified, but intended to fully-fund project
  • Project period: 90 days
  • Purpose: To identify potential treatments, techniques, and datasets to impact public health. Preference given to projects that make their datasets publicly available and referenceable.

IBSA Foundation for Scientific Research

2020 Fellowships – Coronavirus Infections
  • Due: December 31, 2020
  • Funding: € 30,000
  • Project period: 1 year
  • Purpose: To support coronavirus infection research.
  • Eligibility Notes: Researchers under the age of 40, of any nationality, with a degree in medicine, biology, pharmacy, biotechnology or bioengineering, can apply. The call is open to research doctorates and postdocs.

International AIDS Society

CIPHER Grant Program

  • Due: October 30, 2020
  • Funding: $150,000
  • Project period: Two years
  • Purpose: The CIPHER Grant Programme directly supports the development of early-stage investigators, awarding up to US$150,000 for up to two years to address research gaps in paediatric and adolescent HIV in resource-limited settings. The 2020/2021 round will focus on service delivery for HIV and related co-infections for paediatric and adolescent populations in resource-limited settings, including research on:
    • The impact of the COVID-19 pandemic on HIV and related co-infections service delivery
    • Community interventions to improve outcomes along the HIV cascade.
  • Eligibility Note: Applicants must be fewer than 10 years out from terminal research degree and never have served as PI on a non-training grant exceeding $30,000.

Islamic World Educational, Scientific, and Cultural Organization

ICESCO Prize for Fighting Against Coronavirus
  • Due: Nominations open
  • Funding: $200,000
  • Purpose: To reward independent researcher, group of researchers, or institution for discovering effective cure or vaccine against the novel Coronavirus.

Open Road Alliance

Charitable grants and loans in response to COVID-19
  • Due: Open
  • Funding: Not specified
  • Project Period: Not specified
  • Purpose: To support organizations responding directly to COVID-19 that also demonstrate how their intervention moves towards longer term adaptation and systemic/sustainable impact beyond the immediate outbreak. Not research-related.
  • Eligibility Note: Must be non-profit or registered charity.

Paul Scherrer Institut (Swiss)

Priority access call for work on combating COVID-19
  • Due: Rolling through end of 2020
  • Funding: Not specified
  • Project period: Rapid launch, unspecified
  • Purpose: To contribute to the understanding of the virus and/or to improve the clinical or public health response and patient care. Explicitly requires projects that can launch within months.
  • Notes: Short proposal, rapid review. Requires DUO or PSI ID numbers. Links available to obtain.

PurSolutions

Cytoskeleton Reagent Scholarship
  • Due: Rolling, rapid review
  • Funding: Free reagents
  • Project period: Not specified, research ready to launch
  • Purpose: To provide cytoskeleton reagents for COVID research. Coronavirus spike proteins interact with cytoskeleton filaments (i.e. microtubules and actin) for internalization into host cells – a critical step in viral pathogenesis. For some coronaviruses that targeting the cytoskeleton with tubulin or actin inhibitors reduces viral load.
  • Eligibility Note: Application includes all career stages from graduate students to PIs. Brief <=5,000 character, online submission to request free reagents for COVID research.

Robert Wood Johnson Foundation

Pioneering Ideas: Exploring the Future to Build a Culture of Health
  • Due: Open
  • Funding: Not specified
  • Project period: Flexible, typically 1 to 3 years
  • Purpose: To address four areas of focus: 1) future of evidence; 2) future of social interaction; 3) future of food; 5) future of work. Proposals may choose to focus on COVID-19, directly or indirectly, but a response to the pandemic is not required.

Smoke Free World

COVID-19, Smoking, and Nicotine Research
  • Due: December 15, 2020
  • Funding: $150,000 – $500,000
  • Project period: 3 months – 1 year
  • Purpose: The selected organization(s) will implement a range of projects relevant to the global pandemic, including well-designed and comprehensive pre-clinical, clinical, and epidemiological studies, to better understand the associations between smoking and / or nicotine use, and COVID-19 infection and outcomes.
  • Eligibility Notes: The Foundation encourages participation by groups whose work aligns with the Foundation’s mission to eliminate smoking within a generation. These groups may include institutions of higher education, nonprofits, commercial enterprises, governmental agencies, or other research-based organizations.

Society for Medical Decision Making

COVID Decision Modeling Initiative
  • Due: June 30, 2020
  • Funding: Up to $50,000
  • Project period: Up to 6 months
  • Purpose: To catalyze innovative COVID-19 decision models for rapid uptake and impact. The COVID Decision Modeling Initiative (CDMI) will support the development of decision models to inform the urgent needs of decision makers responding to the COVID-19 pandemic.

Turkish Philanthropy Funds

TPF COVID-19 Community Relief Fund
  • Due: Rolling
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To support containment, response and recovery activities for those affected and for the responders.
  • Eligibility Notes: Currently only accepting proposals from TPF partners in Turkey. However, non-profit organizations in the US may email irem@tpfund.org to request consideration.

United States – Israel Binational Science Foundation

BSF Annual Research Grant
  • Due: December 9, 2020
  • Funding: $230,000
  • Project period: 3 years
  • Purpose: To support collaborative research by US and Israeli research teams in the areas of biomedical engineering, life sciences, medicine, psychobiology, exact physical sciences, and social sciences. Proposals related to COVID-19 in these priority areas are welcome.
  • Eligibility Notes: Applications made jointly by US and Israeli researchers. Prior collaboration not required.

Volkswagon Foundation

Corona Crisis and Beyond
  • Due: Rolling
  • Funding: Up to 120,000 euros
  • Project period: Up to 18 months
  • Purpose: To supplement existing projects from any discipline that not only contribute directly to overcoming the crisis, but can also provide impetus for overcoming major societal challenges in the medium to long term.
  • Eligibility Notes: Open to postdoctoral researchers or professors in Germany; single or integrative joint projects (up to 3 partners), international collaborations possible.

Challenges & Innovation Accelerator Competitions

Austrian Academy of Sciences

Prize Question 2020: What Can Science Achieve During Pandemics?  
  • Due: December 31, 2020
  • Funding: Prize amount not specified
  • Project period: N/A
  • Purpose: Essay competition
  • Eligibility Notes: Open to groups and individuals. Entries must be submitted in German, English, French, Italian, Russian or Spanish.

Foundation for Educational Exchange Between Canada and the United States of America

Fulbright Canada Post-COVID Challenge
  • Due: November 30, 2020
  • Funding: 1st Place: $25,000 / 2nd and 3rd Place: $10,000
  • Project period: 6 months
  • Purpose: An open call for youth from across Canada and the United States to provide creative ideas that aim to address critical social, economic, technological, and public health challenges in the post-COVID world.
  • Eligibility Notes: Eligible Fulbright Canada Post-COVID Challenge participants (individuals or teams) are young persons who are the age of majority and reside in Canada or the United States.

InnoCentive

(Use this link for new challenges added often.)

Joint European Disruptive Initiative

Billion Molecules Against COVID-19 JEDI Grand Challenge
  • Due: Stage 2 projected start date Jan. ’21
  • Award: 250,000 euros
  • Purpose: To rapidly identify molecules/peptides/proteins that can block the development and/or spreading of the 2019 Novel Coronavirus (SARS-CoV-2) and stop Covid-19 related disease.
  • Note: There are 3 stages. Teams can participate in one or many.

Kaggle Challenges

(Use this link for new challenges added often.)

Kidney X Innovation Accelerator                                                                         

COVID-19 Kidney Care Challenge
  • Due: December 4, 2020
  • Funding: $20,000
  • Project period: Not specified
  • Purpose: Aims to identify and share solutions that reduce the transmission of coronavirus among people living with kidney disease.
  • Eligibility Notes: Available to United States citizens or legal permanent residents.

The PhRMA Foundation

Challenge Award
  • Due: December 1, 2020 (LOI)
  • Funding: 1st Place: $50,000 / 2nd Place: $25,000 / 3rd & 4th Place: $5,000
  • Anticipated Award Notification: March 1, 2021
  • Purpose: The PhRMA Foundation seeks papers that describe solutions to the following question: “How can value assessment methods and processes better account for populations that are typically underrepresented in research and drivers of health disparities?”
  • Eligibility Notes: Eligible applicants should be affiliated with an academic institution in the United States, U.S. patient group or organization focused on improving health equity in the U.S.

XPRIZE 

XPRIZE Pandemic Response Challenge
  • Due: December 8, 2020
  • Funding: $500,000
  • Project period: 4 months
  • Purpose: To catalyze the development of data-driven systems to construct plans that regional governments, communities, and organizations can implement to minimize harm when reopening their economies.
  • Eligibility Notes: Teams, from all around the world, can be comprised of university groups, high school students, startups and innovators, small to midsize companies, families or individuals.

Other Coronavirus Funding Compilations

See live links in the directory at the top of this post.

For details about the funding sources and compilations for which we conduct scheduled surveillance for funding opportunities, this is the working document enumerating sources and links: bit.ly/34HBOt8

Pardon the dust: these resources are always under construction and not all fields may be complete, with a priority on link accuracy.

Please suggest additions of funding opportunities in comments.

Want to live on the Edge?

Register


Join the conversation

Your email address will not be published. Required fields are marked *


Saving subscription status...

3 Comments
Eigenamin says:

Thank yu so much for this great resources!
It will be really helpful  if  the The Edge for Scholars consider another article  that focuses on postdoc/career transition  funding  opportunities in the context of covid-19 centered research.
Kind regards!

Eigenamin says:

Thank you so much for this great resource!It will be really helpful if the The Edge for Scholars consider another article that focuses on postdoc/career transition funding opportunities in the context of covid-19 centered research.Kind regards!

You May Also Like